uridine has been researched along with Viremia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alter, G; Altfeld, M; Bagchi, A; Frahm, N; Hellman, J; Li, B; Meier, A; Sidhu, H; Stellbrink, HJ; Streeck, H; Teigen, N; van Lunzen, J | 1 |
| Alter, G; Altfeld, M; Brander, C; Meier, A; Streeck, H; Suscovich, TJ; Teigen, N | 1 |
| Clark, JM; Huang, JL; Russell, JW; Soike, KF; Stratton, LW; Sundeen, JE; Whiterock, VJ | 1 |
| Chou, TC; Fox, JJ; Gloff, CA; Soike, KF; Watanabe, KA | 1 |
4 other study(ies) available for uridine and Viremia
| Article | Year |
|---|---|
MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands.
Topics: Animals; Antigens, CD; Antiretroviral Therapy, Highly Active; Biomarkers; CD8-Positive T-Lymphocytes; Cells, Cultured; HIV Infections; HIV-1; Humans; Immune System; Interleukin-6; Ligands; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Myeloid Differentiation Factor 88; Oligonucleotides; RNA, Viral; Toll-Like Receptors; Tumor Necrosis Factor-alpha; Uridine; Viremia | 2007 |
Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells.
Topics: Cells, Cultured; Cytokines; Dendritic Cells; HIV Infections; HIV-1; Humans; Killer Cells, Natural; Ligands; Lymphocyte Activation; Lymphocyte Count; Monocytes; RNA, Viral; Toll-Like Receptor 7; Toll-Like Receptor 8; Uridine; Viremia | 2007 |
Pharmacokinetics and antiviral activity of a novel isonucleoside, BMS-181165, against simian varicella virus infection in African green monkeys.
Topics: Administration, Oral; Animals; Antiviral Agents; Biological Availability; Chlorocebus aethiops; Disease Models, Animal; Herpesviridae Infections; Herpesvirus 1, Cercopithecine; Treatment Outcome; Uridine; Viremia | 1994 |
Inhibition of simian varicella virus infection of monkeys by 1-(2-deoxy-2- fluoro-1-beta-D-arabinofuranosyl)-5-ethyluracil (FEAU) and synergistic effects of combination with human recombinant interferon-beta.
Topics: Adenoviridae Infections; Adenoviruses, Simian; Animals; Antiviral Agents; Arabinofuranosyluracil; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Synergism; Humans; Injections, Intravenous; Interferon Type I; Recombinant Proteins; Uridine; Viremia | 1990 |